Haploidentical, non-myeloablative stem-cell transplantation for advanced renal-cell carcinoma

Author： Satoh M.   Miyamura K.   Yamada M.   Ishidoya S.   Childs R.W.   Arai Y.  

Publisher： Elsevier

ISSN： 1470-2045

Source： Lancet Oncology, Vol.5, Iss.2, 2004-02, pp. : 125-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Haploidentical Stem Cell Transplantation in Childhood

By  

Current Cancer Therapy Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 37-44

Bentham Science Publishers

Access to resources Recommend Favorite

Regression of metastatic renal-cell carcinoma after nonmyeloablative peripheral-blood stem-cell transplantation. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, Read EJ, Tisdale J, Dunbar C, Linehan WM, Young NS, Barrett AJ, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1652, USA.childsr@nih.gov

By Dreicer R.   Dreicer R.   Dreicer R.   Dreicer R.   Dreicer R.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 3, 2001-05 ,pp. : 125-127

Elsevier

Access to resources Recommend Favorite

Mini Test Dose of Intravenous Busulfan (Busulfex®) in Allogeneic Non-Myeloablative Stem Cell Transplantation, Followed by Liquid Chromatography Tandem-Mass Spectrometry

By Spasojevic Ivan   da Costa Ligia R. S.   Horwitz Mitchell E.   Long Gwynn D.   Sullivan Keith M.   Chute John P.   Gasparetto Cristina   Morris Ashley   Chao Nelson J.   Rizzieri David A.  

Cancer Investigation, Vol. 30, Iss. 9, 2012-10 ,pp. : 679-682

Informa Healthcare

Access to resources Recommend Favorite

Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma

By Liso A.   Tiacci E.   Binazzi R.   Pulford K.   Benedetti R.   Carotti A.   Aversa F.   Falini B.  

Lancet Oncology, Vol. 5, Iss. 2, 2004-02 ,pp. : 127-128

Elsevier

Access to resources Recommend Favorite

Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia

By Hebenstreit Karin   Iacobelli Simona   Leiblein Sabine   Eisfeld Ann-Kathrin   Pfrepper Christian   Heyn Simone   Vucinic Vladan   Franke Georg-Nikolaus   Krahl Rainer   Fricke Stephan   Becker Cornelia   Pönisch Wolfram   Behre Gerhard   Niederwieser Dietger   Lange Thoralf  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1274-1280

Informa Healthcare

Access to resources Recommend Favorite